NIBIOHN Looks to Spur Next-Gen Drug Development with Unique Antibody Techs, Joins Hands with 10 Companies

The National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN) is poised to tap its unique technologies to give a boost to the development of next-generation nucleic acid-based drugs and small-molecule drugs that carry antibody-like functions and characteristics. NIBIOHN’s Center...read more